{"symbol":"AMGN","fiscalQuarter":"Q4-2017","reportDate":"2018-02-01","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2017","postBrief":{"headline":"Amgen Misses on EPS \u2014 Stock Down 0.26%","keyNumbers":[{"metric":"EPS","actual":"$2.89","expected":"N/A","surprise":"-7.27%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management acknowledged the challenging market conditions.","They emphasized their commitment to innovation and pipeline development."],"summary":"Overall, management expressed a cautious outlook while highlighting their focus on future growth. They did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report showed a miss on EPS, which contributed to a slight decline in stock price by 0.26%. Investors may be concerned about the company's performance amidst challenging market conditions. The lack of revenue data and forward guidance adds uncertainty to the outlook.","metaDescription":"Amgen (AMGN) Q4 2017 earnings: EPS missed expectations. Stock down 0.26%. Full breakdown."}}